StonvexLoading…
StonvexStonvexStonvexCore line items from CFBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $120.00M | $118.39M | $108.28M | $67.76M |
Operating Income | $21.53M | $16.14M | $20.98M | $22.59M |
Net Income | $17.54M | $13.39M | $16.94M | $18.16M |
EPS (Diluted) | $2.69 | $2.06 | $2.63 | $2.78 |
Total Assets | $2.12B | $2.07B | $2.06B | $1.82B |
Total Liabilities | $1.93B | $1.90B | $1.90B | $1.68B |
Cash & Equivalents | $258.97M | $235.27M | $261.60M | $151.79M |
Free Cash Flow OCF − CapEx | $18.20M | $13.92M | $17.39M | $38.86M |
Shares Outstanding | 6.33M | 6.31M | 6.45M | 6.54M |